Sneeuw K C, Aaronson N K, Osoba D, Muller M J, Hsu M A, Yung W K, Brada M, Newlands E S
Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Med Care. 1997 May;35(5):490-506. doi: 10.1097/00005650-199705000-00006.
The use of self-report questionnaires for the assessment of health-related quality of life (HRQOL) is increasingly common in clinical research. This method of data collection may be less suitable for patient groups who suffer from cognitive impairment, however, such as patients with brain cancer. In such cases, one can consider employing the patients' significant others as proxy raters of the patients' health-related quality of life. The authors examined the response agreement between patients with brain cancer and their significant others on a health-related quality of life instrument commonly used in cancer clinical trials, the EORTC QLQ-C30, and on a brain cancer-specific questionnaire module, the QLQ-BCM.
The study sample consisted of 103 pairs of patients, with either recently diagnosed or recurrent brain cancer, and their significant others (75% spouses, 22% relatives, and 3% friends). Patients and proxies independently completed the EORTC QLQ-C30 and the QLQ-BCM at three different times.
Approximately 60% of the patient and proxy scores were in exact agreement, with more than 90% of scores being within one response category of each other. For most HRQOL dimensions assessed, moderate to good agreement was found. Statistically significant differences in mean scores were noted for several dimensions, with proxies tending to rate the patients as having a lower quality of life than the patients themselves. With the exception of fatigue ratings, this response bias was of a limited magnitude. Less agreement and a more pronounced response bias was observed for the more impaired patients, and particularly for patients exhibiting mental confusion. This finding was confirmed by longitudinal analyses, which indicated lower levels of patient-proxy agreement at follow-up for those patients whose physical or neurologic condition had deteriorated over time.
In general, patients and their significant others provide similar ratings of the patients' quality of life. Lower levels of agreement and more biased ratings can be expected among those patients for whom the need for proxies is most salient. It is argued, however, that discrepancies between patient-proxy ratings should not be interpreted, a priori, as evidence of the inaccuracy or biased nature of proxy-generated data. Future studies are needed to examine the relative validity and reliability of patient-versus proxy-generated health-related quality of life scores.
在临床研究中,使用自我报告问卷来评估健康相关生活质量(HRQOL)越来越普遍。然而,这种数据收集方法可能不太适用于患有认知障碍的患者群体,比如脑癌患者。在这种情况下,可以考虑让患者的重要他人作为患者健康相关生活质量的代理评分者。作者研究了脑癌患者与其重要他人在癌症临床试验中常用的一种健康相关生活质量工具——欧洲癌症研究与治疗组织核心问卷(EORTC QLQ-C30)以及一个脑癌特异性问卷模块——QLQ-BCM上的回答一致性。
研究样本包括103对患者,这些患者患有新诊断或复发性脑癌,以及他们的重要他人(75%为配偶,22%为亲属,3%为朋友)。患者和代理评分者在三个不同时间独立完成EORTC QLQ-C30和QLQ-BCM。
大约60%的患者和代理评分完全一致,超过90%的评分在彼此的一个回答类别范围内。对于所评估的大多数HRQOL维度,发现了中度到良好的一致性。在几个维度上注意到平均得分存在统计学上的显著差异,代理评分者倾向于将患者的生活质量评为低于患者自己的评分。除了疲劳评分外,这种回答偏差的程度有限。对于受损更严重的患者,尤其是表现出精神混乱的患者,观察到一致性较低且回答偏差更明显。纵向分析证实了这一发现,该分析表明,对于那些身体或神经状况随时间恶化的患者,随访时患者与代理评分者的一致性水平较低。
总体而言,患者及其重要他人对患者生活质量的评分相似。对于那些最需要代理评分者的患者,预计一致性水平较低且评分偏差更大。然而,有人认为,患者与代理评分之间的差异不应先验地解释为代理生成数据不准确或有偏差的证据。未来需要进行研究,以检验患者与代理生成的健康相关生活质量评分的相对有效性和可靠性。